HYGEIA'S DRUG PRODUCT PIPELINE
HYG-102 is the lead of 10 estrogenic candidates for the topical treatment of Age-related Skin Fragility and Vaginal Atrophy.
HYG-440 is the lead of four structural classes of anti-androgenic candidates for the topical treatment of Acne, Hirsutism, Seborrhea and Androgenic Alopecia (hair loss due to excess androgens in the scalp).
HYG-102440, the combination of HYG-102 and HYG-440, is also being developed for the topical treatment of hair loss due to excess androgen activity in the scalp.
| Candidate | Indication | Preclinical | Phase I | Phase II |
|---|---|---|---|---|
HYG-102 |
Skin Fragility/Vaginal Atrophy |
 |
||
HYG-101 |
Skin Fragility/Vaginal Atrophy |
|
||
HYG-440 |
Acne, Hirsutism, Alopecia |
|
||
HYG-430 |
Acne, Hirsutism, Alopecia |
|
||
HYG-420 |
Acne, Hirsutism, Alopecia |
|
||
HYG-410 |
Acne, Hirsutism, Alopecia |
|
||
HYG-102440 |
Androgenic Alopecia |
|
||
HYG-112 |
Other topical |
|
||
HYG-113 |
Other topical |
|
||
HYG-114 |
Other topical |
|
||
HYG-104 |
Other topical |
|